Pacer Advisors’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-688
Closed -$16.1K 2533
2024
Q2
$16.1K Sell
688
-677
-50% -$15.9K ﹤0.01% 3446
2024
Q1
$34.5K Buy
+1,365
New +$34.5K ﹤0.01% 3317
2021
Q2
Sell
-1,034
Closed -$30K 1402
2021
Q1
$30K Sell
1,034
-216
-17% -$6.27K ﹤0.01% 1479
2020
Q4
$32K Buy
+1,250
New +$32K ﹤0.01% 1456